The ADNI Private Partner Scientific Board (PPSB) Update for 2015 highlights key leadership, partner organizations, deliverables, and accomplishments in advancing drug development. Susan De Santi as Chairperson, along with industry leaders, plays a crucial role in advising and collaborating with ADNI

0 views • 23 slides

Veronika Logovinsky, MD, PhD, chaired the ADNI Private Partner Scientific Board (PPSB) meeting on July 14, 2017. The PPSB, comprising leadership and working groups, focuses on providing advice for ADNI 3 implementation and accelerating drug development. The Clinical Endpoints Working Group, led by V

0 views • 21 slides